ARTICLE | Company News
Sparta other research news
April 15, 2013 7:00 AM UTC
SPTA received a $750,000 two-year Phase II SBIR grant from the National Institute of Neurological Disorders and Stroke to research the use of a serine protease inhibitor to treat reperfusion injury. T...